195 related articles for article (PubMed ID: 15096540)
1. T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes.
Juedes AE; Rodrigo E; Togher L; Glimcher LH; von Herrath MG
J Exp Med; 2004 Apr; 199(8):1153-62. PubMed ID: 15096540
[TBL] [Abstract][Full Text] [Related]
2. PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner.
Fousteri G; Jofra T; Di Fonte R; Kuka M; Iannacone M; Battaglia M
Clin Immunol; 2015 Feb; 156(2):98-108. PubMed ID: 25513733
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence.
Holz A; Bot A; Coon B; Wolfe T; Grusby MJ; von Herrath MG
J Immunol; 1999 Nov; 163(10):5374-82. PubMed ID: 10553062
[TBL] [Abstract][Full Text] [Related]
4. CD103 is dispensable for anti-viral immunity and autoimmunity in a mouse model of virally-induced autoimmune diabetes.
Fousteri G; Dave A; Juntti T; von Herrath M
J Autoimmun; 2009 Feb; 32(1):70-7. PubMed ID: 19162441
[TBL] [Abstract][Full Text] [Related]
5. Antigen-driven effector CD8 T cell function regulated by T-bet.
Sullivan BM; Juedes A; Szabo SJ; von Herrath M; Glimcher LH
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15818-23. PubMed ID: 14673093
[TBL] [Abstract][Full Text] [Related]
6. Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model.
Bresson D; von Herrath MG
Clin Exp Immunol; 2011 Mar; 163(3):375-80. PubMed ID: 21235534
[TBL] [Abstract][Full Text] [Related]
7. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
8. SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes.
Barral AM; Thomas HE; Ling EM; Darwiche R; Rodrigo E; Christen U; Ejrnaes M; Wolfe T; Kay TW; von Herrath MG
J Autoimmun; 2006 Nov; 27(3):166-73. PubMed ID: 17045460
[TBL] [Abstract][Full Text] [Related]
9. Protection from type 1 diabetes in the face of high levels of activated autoaggressive lymphocytes in a viral transgenic mouse model crossed to the SV129 strain.
von Herrath MG; Wolfe T; Möhrle U; Coon B; Hughes A
Diabetes; 2001 Dec; 50(12):2700-8. PubMed ID: 11723052
[TBL] [Abstract][Full Text] [Related]
10. Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.
Wiesel M; Crouse J; Bedenikovic G; Sutherland A; Joller N; Oxenius A
Eur J Immunol; 2012 Feb; 42(2):320-9. PubMed ID: 22102057
[TBL] [Abstract][Full Text] [Related]
11. Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearance.
von Herrath MG; Coon B; Wolfe T; Chatenoud L
J Immunol; 2002 Jan; 168(2):933-41. PubMed ID: 11777992
[TBL] [Abstract][Full Text] [Related]
12. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17.
Rangachari M; Mauermann N; Marty RR; Dirnhofer S; Kurrer MO; Komnenovic V; Penninger JM; Eriksson U
J Exp Med; 2006 Aug; 203(8):2009-19. PubMed ID: 16880257
[TBL] [Abstract][Full Text] [Related]
13. T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses.
Baumann C; Bonilla WV; Fröhlich A; Helmstetter C; Peine M; Hegazy AN; Pinschewer DD; Löhning M
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4056-61. PubMed ID: 25829541
[TBL] [Abstract][Full Text] [Related]
14. T-bet is essential for the progression of experimental autoimmune encephalomyelitis.
Nath N; Prasad R; Giri S; Singh AK; Singh I
Immunology; 2006 Jul; 118(3):384-91. PubMed ID: 16827899
[TBL] [Abstract][Full Text] [Related]
15. Th2 cells lacking T-bet suppress naive and memory T cell responses via IL-10.
Muñoz M; Hegazy AN; Brunner TM; Holecska V; Marek RM; Fröhlich A; Löhning M
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33526653
[TBL] [Abstract][Full Text] [Related]
16. T-bet is required for protection against vaccinia virus infection.
Matsui M; Moriya O; Yoshimoto T; Akatsuka T
J Virol; 2005 Oct; 79(20):12798-806. PubMed ID: 16188982
[TBL] [Abstract][Full Text] [Related]
17. [Viral antigen induced autoimmunity: an animal model for diabetes mellitus type I].
Hengartner H
Verh Dtsch Ges Pathol; 1994; 78():177-9. PubMed ID: 7533982
[TBL] [Abstract][Full Text] [Related]
18. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.
Szabo SJ; Sullivan BM; Stemmann C; Satoskar AR; Sleckman BP; Glimcher LH
Science; 2002 Jan; 295(5553):338-42. PubMed ID: 11786644
[TBL] [Abstract][Full Text] [Related]
19. IL-21 promotes CD8+ CTL activity via the transcription factor T-bet.
Sutherland AP; Joller N; Michaud M; Liu SM; Kuchroo VK; Grusby MJ
J Immunol; 2013 Apr; 190(8):3977-84. PubMed ID: 23479229
[TBL] [Abstract][Full Text] [Related]
20. A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory.
Singh A; Suresh M
J Leukoc Biol; 2007 Nov; 82(5):1201-11. PubMed ID: 17704295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
